Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression
NEURO4C
1 other identifier
interventional
198
1 country
2
Brief Summary
The goal of this clinical trial is to test the efficacy of a transdiagnostic Internet-delivered interventions for Romanian adolescents with anxiety and/ or depression. The main questions it aims to answer are:
- What is the clinical efficacy of the Internet-delivered intervention?
- How accurate is the prediction model in predicting who will respond to treatment? Participants will undergo non-invasive fMRI to measure variability in brain signal as a proxy of the neural systems' adaptability before receiving the intervention, then they will be allocated either to the Internet-delivered intervention or control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedApril 4, 2025
April 1, 2025
9 months
December 2, 2024
April 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Internalizing problems
Change from baseline in internalizing problems. Revised Children's Anxiety and Depression Scale (RCADS) completed by adolescents.
baseline, after 8 weeks of intervention, 6 months follow-up
Secondary Outcomes (16)
Clinical diagnosis
administered pre-baseline, post-baseline (after 8 week waitlist period), after 8 weeks of intervention
Global functioning
baseline, after 8 weeks of intervention, 6 months follow-up
Severity
baseline, after 8 weeks of intervention, 6 months follow-up
Improvement
after 8 weeks of intervention, 6 months follow-up
Comorbid problems
baseline, after 8 weeks of intervention, 6 month follow-up
- +11 more secondary outcomes
Study Arms (2)
Transdiagnostic Internet-delivered intervention
EXPERIMENTALThe intervention consists of 8 modules delivered over 8 weeks. It is based on Rational Emotive Behavioral Therapy (REBT).
Control group
NO INTERVENTIONParticipants in the control group are a delayed intervention group (waiting list control). They will access the intervention after 8 weeks.
Interventions
The intervention consists of 8 modules based on Rational emotive therapy, delivered via 8 weeks.
Eligibility Criteria
You may qualify if:
- elevated symptoms of anxiety or depression/ internalizing problems (T score\> 60) at intake (based on Youth self-report completed by adolescents)
- primary diagnosis of an anxiety/depressive disorder based on DSM-5 criteria according to ADIS-5-C/P interview
- age 13-17
- able to read and understand Romanian language
- Currently unmedicated or on stable and adequate doses of medication for at least 6 weeks before treatment onset
- Internet access
You may not qualify if:
- severe mental disorder (psychosis, severe depression, bipolar disorder, based on clinical interview)
- any condition that interferes with the protocol implementation (e.g., physical illness or sensory impairment that interferes with behavioral tasks such as exposure, behavioral activation, unavailable for the next 3 months),
- active suicidal ideation (assessed by child psychiatrist during clinical interview) in the last month
- currently following CBT/ psychotherapy for anxiety/depression, in the last 6 months
- fMRI incompatible (based on safety questionnaire)
- Being diagnosed with an intellectual disability, pervasive developmental disorder, an alcohol and/or substance dependence disorder, reading disabilities (based on clinical interview).
- Current treatment with benzodiazepines
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Babes-Bolyai University
Cluj-Napoca, 400015, Romania
Babeș-Bolyai University
Cluj-Napoca, 400015, Romania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Costina Poetar, PhD
Babeș-Bolyai University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
December 2, 2024
First Posted
December 9, 2024
Study Start
April 1, 2025
Primary Completion
December 31, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
April 4, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Supporting information will be shared after the publication of the results.
- Access Criteria
- Supporting information will be publicly shared in OSF.
Deidentified individual participant data will be will be shared after the publication of the results.